MYLAN 2537 MYLAN 2537 (Hydrochlorothiazide and triamterene 25 mg / 37.5 mg)
Pill imprint MYLAN 2537 MYLAN 2537 has been identified as Hydrochlorothiazide and triamterene 25 mg / 37.5 mg.
Hydrochlorothiazide/triamterene is used in the treatment of edema; high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/triamterene 25 mg / 37.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 2537 MYLAN 2537
- 25 mg / 37.5 mg
- Green & Yellow
- 12.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
ferric oxide yellow
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|51079-0935||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide/triamterene
- Hydrochlorothiazide and triamterene
- Triamterene and hydrochlorothiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.